FibroGen, Inc.

FGEN · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$13-$8$5$18
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$2$3$0
Change in WC-$160$18-$6-$48
Other Non-Cash$171$0$1-$1
Operating Cash Flow-$2$13$3-$30
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$90$0$0$0
Inv. Purchases-$3$0$0$0
Inv. Sales/Matur.$0$0$0$2
Other Inv. Act.$0$0$0$0
Investing Cash Flow$87-$0-$0$2
Financing Activities
Debt Repay.-$81$0-$0-$0
Stock Issued$0$0$0$0
Stock Repurch.$0-$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$5$0-$0-$0
Financing Cash Flow-$86-$0-$0$0
Forex Effect$95$1$1-$0
Net Chg. in Cash$95$14$4-$29
Supplemental Information
Beg. Cash$23$106$102$131
End Cash$118$120$106$102
Free Cash Flow-$2$13$3-$31
FibroGen, Inc. (FGEN) Financial Statements & Key Stats | AlphaPilot